Reference health

Early safety assessment of human oculotoxic drugs using the zebrafish visualmotor response

https://doi.org/10.1016/j.vascn.2013.09.002
CiteStamped reference-health badge
35/35 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

3 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 35 checked references that resolve
resolves10.1006/gyno.1998.5211
Cortical Blindness as a Manifestation of Hypomagnesemia Secondary to Cisplatin Therapy: Case Report and Review of Literature
resolves10.1038/bjp.2008.249
Zebrafish: an emerging technology for <i>in vivo</i> pharmacological assessment to identify potential safety liabilities in early drug discovery
resolves10.1038/nprot.2006.255
Measuring the optokinetic response of zebrafish larvae
resolves10.1073/pnas.92.23.10545
A behavioral screen for isolating zebrafish mutants with visual system defects.
resolves10.1111/j.1600-0404.1997.tb00280.x
Recovering optic neuritis during systemic cisplatin and carboplatin chemotherapy
resolves10.1172/JCI29999
Drug discovery in jeopardy
resolves10.1016/0002-9394(85)90792-5
Comparative Toxicity of Intravitreal Aminoglycoside Antibiotics
resolves10.1016/j.neurol.2012.07.013
Atypical forms of optic neuritis
resolves10.1136/bmj.291.6487.31
Death and blindness due to overdose of quinine.
resolves10.1006/dbio.1996.0335
The Development of Vision in the Zebrafish (Danio rerio)
resolves10.1167/iovs.10-5392
Ophthalmic Drug Delivery Systems for the Treatment of Retinal Diseases: Basic Research to Clinical Applications
resolves10.3791/923
A Behavioral Assay to Measure Responsiveness of Zebrafish to Changes in Light Intensities
resolves10.1016/j.preteyeres.2007.08.002
Zebrafish: A model system for the study of eye genetics
resolves10.1089/zeb.2006.3.191
Visual Behavior in Zebrafish
resolves10.1016/j.ophtha.2003.12.052
Adverse ocular drug reactions recently identified by the National Registry of Drug-Induced Ocular Side Effects
resolves10.1345/aph.1G451
Optic Neuritis with Visual Field Defect—Possible Ibuprofen-Related Toxicity
resolves10.1016/S1084-9521(02)00167-2
The zebrafish as a tool for understanding the biology of visual disorders
resolves10.1016/0039-6257(94)90157-0
The vascular endothelium as a regulator of the ocular circulation: A new concept in ophthalmology?
resolves10.1002/aja.1002030302
Stages of embryonic development of the zebrafish
resolves10.1038/nrd1470
Can the pharmaceutical industry reduce attrition rates?
resolves10.1016/j.ajo.2005.07.046
Retinal Ischemia With Neovascularization in Cisplatin Related Retinal Toxicity
resolves10.1136/bjo.86.11.1259
Acquired colour vision deficiency in patients receiving digoxin maintenance therapy
resolves10.3791/3556
VisioTracker, an Innovative Automated Approach to Oculomotor Analysis
resolves10.1523/JNEUROSCI.19-19-08603.1999
Genetic Disorders of Vision Revealed by a Behavioral Screen of 400 Essential Loci in Zebrafish
resolves10.1167/iovs.06-0728
New Tools for the Evaluation of Toxic Ocular Surface Changes in the Rat
resolves10.1242/dmm.006429
Harmonin (Ush1c) is required in zebrafish Müller glial cells for photoreceptor synaptic development and function
resolves10.1038/bjc.2011.6
A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours
resolves10.1016/j.vascn.2008.05.006
Zebrafish assays as early safety pharmacology screens: Paradigm shift or red herring?
resolves10.1016/j.vascn.2008.04.002
Validation of the use of zebrafish larvae in visual safety assessment
resolves10.2165/00003495-200767010-00006
Ocular Adverse Effects Associated with Systemic Medications
resolves10.1016/j.survophthal.2005.11.001
Update on Ocular Complications of Systemic Cancer Chemotherapy
resolves10.1186/1478-811X-8-11
Small molecule screening in zebrafish: an in vivo approach to identifying new chemical tools and drug leads
resolves10.1016/S0896-1549(05)70261-3
GENTAMICIN AND OTHER ANTIBIOTIC TOXICITIY
resolves10.1089/adt.2006.4.695
Investigating Cytoskeletal Alterations as a Potential Marker of Retinal and Lens Drug-Related Toxicity
resolves10.1371/journal.pone.0052177
Inhibition of the Pim1 Oncogene Results in Diminished Visual Function
The 3 references without a DOI — listed, not checked
no DOI — not checkedEnabling technologies in reducing drug attrition due to safety failures
no DOI — not checkedBilateral optic neuritis following minoxidil administration
no DOI — not checked10.1016/j.vascn.2013.09.002_bb0205
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

view as graph · paper page

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1016/j.vascn.2013.09.002"><img src="https://citestamp.com/citestamped/10.1016/j.vascn.2013.09.002/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1016/j.vascn.2013.09.002/badge.svg)](https://citestamp.com/citestamped/10.1016/j.vascn.2013.09.002)